Out of focus but still relevant? Influenza-related resource utilization and vaccination coverage gaps in adults below 60 years of age with underlying conditions: an analysis of 2016–2024 real-world data in Germany
Open Access
- 18 October 2024
- journal article
- research article
- Published by Taylor & Francis in Journal of Medical Economics
- Vol. 27 (1) , 1337-1346
Abstract
Background: In 2003, the WHO aimed for a 75% or higher influenza vaccination rate among at-risk populations. However, this target was achieved in a few groups during selected seasons in some European countries, and never in Germany. Adults with underlying conditions (UCs) are a critical negleted group for influenza vaccination. This study aimed to identify data gaps in influenza burden and vaccination coverage among adults under 60 with UCs in Germany and bridge these gaps using real-world data.Material and Methods: We conducted systematic research and analyses using German administrative and claims databases from June 2016 to April 2024. We report on epidemiology, direct care costs, indirect costs from work incapacity, vaccination coverage rates, and describe data gaps.Results: Influenza data for high-risk populations are limited. Comprehensive data on influenza epidemiology and vaccination coverage rates (VCR) is available, though with a delay in data availability. Before and after the pandemic, individuals aged 50-59 had the highest rates of influenza-related hospitalization and ICU admission compared to younger age groups. Across all age groups and seasons, individuals with UC experienced higher rates of medically attended influenza cases, hospitalizations, and healthcare costs, with those aged 35-59 being particularly vulnerable. Vaccine coverage was higher in adults aged 35-59 compared to those aged 18-24, and in females compared to males.Limitations: Discrepancies of vaccination status, limited data availability, and variations among the extent of UCs.Conclusion: In Germany, recent policy measures have mainly targeted those aged 60 and above. While this elderly population experiences the highest disease-related impact, influenza can also lead to substantial healthcare resource utilization (HCRU) and costs in younger populations with chronic UCs; Facilitating vaccination access for this group, such as through pharmacies, is essential. Definition of quantifiable vaccination targets and measures to increase vaccination rates based on these targets are required.Keywords
This publication has 39 references indexed in Scilit:
- Understanding the Global Burden of Influenza in Adults Aged 18–64 years: A Systematic Literature Review from 2012 to 2022Advances in Therapy, 2023
- High Clinical Burden of Influenza Disease in Adults Aged ≥ 65 Years: Can We Do Better? A Systematic Literature ReviewAdvances in Therapy, 2023
- Systematisches Review zur Schätzung der Prävalenz entzündlich rheumatischer Erkrankungen in DeutschlandZeitschrift für Rheumatologie, 2023
- Burden of influenza in Germany: a retrospective claims database analysis for the influenza season 2012/2013The European Journal of Health Economics, 2015
- Association Between Influenza Vaccination and Cardiovascular Outcomes in High-Risk PatientsJAMA, 2013
- Annual All-Cause Healthcare Costs Among Influenza Patients With and Without Influenza-Related ComplicationsApplied Health Economics and Health Policy, 2013
- Effect of Influenza Vaccination of Children on Infection Rates in Hutterite CommunitiesJAMA, 2010
- Cost‐effectiveness of influenza vaccination in working‐age cancer patientsCancer, 2007
- Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in childrenVaccine, 2005
- Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against InfluenzaArchives of internal medicine (1960), 2001